Trend Screener

Glenmark Pharmaceuticals Share Price GLENMARK

Glenmark Pharmaceuticals Limited
Open Chart
₹2,225.80
+2.73%
Today High / Low ₹2,229.00 / ₹2,133.00
52W High / Low ₹2,537.60 / ₹1,798.60
Trend Screener Score 15%  |  Very Strong Bearish

GLENMARK Trend Matrix

Monthly Trend Bearish / Res.. - ₹2,256.40
Weekly Trend Bearish / Res.. - ₹2,230.10
Daily Trend Bearish / Res.. - ₹2,196.00
Hourly Trend Bullish / Sup.. - ₹2,225.00
15M Trend Bullish / Sup.. - ₹2,225.60
CMP vs S/R NO

RSI Momentum Values

Monthly RSI 60.51
Weekly RSI 47.31
Daily RSI 43.06

Moving Average Confluence (SMA)

SMA 200 ₹2,227.95
SMA 100 ₹2,290.92
SMA 50 ₹2,355.68
SMA 20 ₹2,264.43
SMA 10 ₹2,219.39
Overall Trend: Trend is weak and sellers are still in control. Until the price starts showing strength again, any upside move may struggle to continue.

Momentum: RSI is around 50.29, which gives buyers a slight edge. A stronger move above this level would improve momentum further. Short-term charts (hourly and 15-minute) are also looking bullish, backing up the near-term buying momentum.

Moving Averages: Price is trading below all major moving averages, which is generally a sign of weakness and seller dominance. The price is also below the 200-day SMA, which keeps the long-term trend weak.

Key Levels: The next major resistance is near ₹2,256.40. The nearest resistance is around ₹2,230.10. Today's range has been between ₹2,133.00 and ₹2,229.00. The stock is positioned right in the middle of its 52-week range.

Trend Summary: Very Strong Bearish. The trend is still weak. It is better to wait for a clear sign of strength before considering fresh buying.
Market Capitalisation See Ratios Below ↓
Key Statements See Ratios Below ↓

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited develops, manufactures and markets generic, specialty and over-the-counter pharmaceutical products in India and international markets. Its portfolio covers therapeutic areas including dermatology, respiratory care, oncology, immunology, cardiology, diabetes, pain management, gastroenterology and anti-infectives. The company develops products across oral, injectable, topical and respiratory dosage forms and also maintains a pipeline of specialty and biologic drug candidates. Incorporated in 1977, Glenmark Pharmaceuticals is based in Mumbai, India.

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Website: Official Website

Similar Stocks (NIFTY 200 Peers)

Glenmark Pharmaceuticals Limited (Glenmark Pharmaceuticals) Share Price & Technical Analysis

Track the latest Glenmark Pharmaceuticals Limited share price along with important technical indicators in one place. This page provides a quick overview of the stock's current trend, momentum, and key price levels without switching between multiple charts.

You can check the live market price, Monthly, Weekly, Daily and Intraday trends, RSI values, Moving Averages (SMA), support & resistance levels, and the stock's 52-week high and low to better understand its overall market position.

Trend Screener automatically updates market data throughout trading hours, helping traders and investors stay informed with the latest technical analysis and trend information for 250+ NSE stocks.

Glenmark Pharmaceuticals Limited (Glenmark Pharmaceuticals) Technical Analysis Overview

This page brings together the most important technical indicators for Glenmark Pharmaceuticals Limited in one place. Instead of checking multiple charts, you can quickly review the stock's price action, trend, momentum, and key support and resistance levels from a single dashboard.

Whether you are an intraday trader, swing trader, or long-term investor, this page helps you quickly understand the current technical picture of Glenmark Pharmaceuticals before making your own investment decisions.

Disclaimer: TrendScreener.in is an educational stock analysis platform and is not a SEBI-registered Research Analyst or Investment Advisor. The information on this page is generated using technical indicators and market data and should not be considered as investment advice or buy/sell recommendations. Please do your own research before investing.